Psychiatric adverse events associated with GLP-1 receptor agonists: a real-world pharmacovigilance study based on the FDA Adverse Event Reporting System database

Overview of attention for article published in Frontiers in endocrinology, February 2024

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age (67th percentile)
High Attention Score compared to outputs of the same age and source (91st percentile)

So far, Altmetric has seen 11 X posts from 8 X users, with an upper bound of 15,034 followers.

“Conclusion: Our findings demonstrate a significant association between GLP-1 RAs and the development of specific psychiatric AEs.” - https://t.co/IWF4lJKD0s Links for above research: https://t.co/cABJiyxP4y https://t.co/fbCgLJHoUr https://t.co/21SVox3VT

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 7 additional X posts.